Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve
- 25 May 1999
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (3) , 1667-1668
- https://doi.org/10.1016/s0041-1345(99)00089-5
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- A RANDOMIZED, PROSPECTIVE MULTICENTER PHARMACOEPIDEMIOLOGIC STUDY OF CYCLOSPORINE MICROEMULSION IN STABLE RENAL GRAFT RECIPIENTS1,2,3Transplantation, 1996
- EVIDENCE FOR EARLIER STABILIZATION OF CYCLOSPORINE PHARMACOKINETICS IN DE NOVO RENAL TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATIONTransplantation, 1996
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993
- THE RELATIONSHIP BETWEEN CYCLOSPORINE PHARMACOKINETIC PARAMETERS AND SUBSEQUENT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1988